Frontiers in Genetics | Cancer Genetics and Oncogenomics

Original Research

Published on 11 Jan 2023

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer

in Cancer Genetics and Oncogenomics

Yuhang Wang
Kai Wang
Han Zhang
Xiaoteng Jia
Xin Li
Shuai Sun
Daqiang Sun

Frontiers in Genetics

doi 10.3389/fgene.2022.1068462

5,921 views
7 citations

Original Research

Published on 10 Jan 2023

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit

in Cancer Genetics and Oncogenomics

Yue Hou
Sijing Qiao
Miao Li
Xue Han
Xuan Wei
Yingxin Pang
Hongluan Mao

Frontiers in Genetics

doi 10.3389/fgene.2022.1090640

9,025 views
27 citations

Editorial

Published on 10 Jan 2023

Editorial: Molecular basis of epigenetic regulation in cancer therapies

in Cancer Genetics and Oncogenomics

Angeles Carlos-Reyes
Susana Romero-Garcia
César López-Camarillo
Guillermo Barreto
Heriberto Prado-Garcia

Frontiers in Genetics

doi 10.3389/fgene.2022.1115353

2,003 views
1 citation

Review

Published on 10 Jan 2023

Epigenetic modifications in esophageal cancer: An evolving biomarker

in Cancer Genetics and Oncogenomics

Wen-Jian Liu
Yuan Zhao
Xu Chen
Man-Li Miao
Ren-Quan Zhang

Frontiers in Genetics

doi 10.3389/fgene.2022.1087479

6,496 views
14 citations

Original Research

Published on 10 Jan 2023

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer

in Cancer Genetics and Oncogenomics

Cheng Xin
Yi Lai
Liqiang Ji
Ye Wang
Shihao Li
Liqiang Hao
Wei Zhang
Ronggui Meng
Jun Xu
Yonggang Hong

Frontiers in Genetics

doi 10.3389/fgene.2022.1097234

3,982 views
10 citations

Original Research

Published on 10 Jan 2023

Identification and validation of a TTN-associated immune prognostic model for skin cutaneous melanoma

in Cancer Genetics and Oncogenomics

Qirui Wang
Xingtai Huang
Siyi Zeng
Renpeng Zhou
Danru Wang

Frontiers in Genetics

doi 10.3389/fgene.2022.1084937

3,895 views
7 citations

Original Research

Published on 10 Jan 2023

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer

in Cancer Genetics and Oncogenomics

Hangbin Ma
Cheng Zhou
Jianchao Ge
Wandong Yu
Yinghao Zhou
Pengyu Wang
Xuehu Zhang
Jun Zhang
Guowei Shi

Frontiers in Genetics

doi 10.3389/fgene.2022.1110723

3,233 views
4 citations

Original Research

Published on 09 Jan 2023

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma

in Cancer Genetics and Oncogenomics

Zhi Liu
Jun Zhang
Deyun Shen
Xuechun Hu
Zongpan Ke
I Nyoman Ehrich Lister
Bungaran Sihombing

Frontiers in Genetics

doi 10.3389/fgene.2022.873884

3,886 views
4 citations

Original Research

Published on 09 Jan 2023

Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer

in Cancer Genetics and Oncogenomics

Jing Zhang
Jiawen Zhang
Weiwei Zhao
Qingxian Li
Wenwu Cheng

Frontiers in Genetics

doi 10.3389/fgene.2022.1067826

4,384 views
11 citations

Original Research

Published on 09 Jan 2023

Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia

in Cancer Genetics and Oncogenomics

Yong Liu
Jing Zhang
Zefan Du
Junbin Huang
Yucai Cheng
Wenfang Yi
Tianwen Li
Jing Yang
Chun Chen

Frontiers in Genetics

doi 10.3389/fgene.2022.1087938

7,186 views
13 citations

Original Research

Published on 09 Jan 2023

Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion

in Cancer Genetics and Oncogenomics

Bao Zhang
Shenghan Wang
Zhichao Fu
Qiang Gao
Lin Yang
Zhentao Lei
Yuqiang Shi
Kai Le
Jie Xiong
Siyao Liu

Frontiers in Genetics

doi 10.3389/fgene.2022.1073232

7,989 views
13 citations

Original Research

Published on 09 Jan 2023

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers

in Cancer Genetics and Oncogenomics

Jiali Dai
Yanan Cui
Xiao Liang
Jiali Xu
Jun Li
Yu Chen
Erbao Zhang
Renhua Guo

Frontiers in Genetics

doi 10.3389/fgene.2022.1066347

7,255 views
19 citations

Original Research

Published on 09 Jan 2023

Cuproptosis-associated CDKN2A is targeted by plicamycin to regulate the microenvironment in patients with head and neck squamous cell carcinoma

in Cancer Genetics and Oncogenomics

Kaihui Fan
Yuke Dong
Tao Li
Yujie Li

Frontiers in Genetics

doi 10.3389/fgene.2022.1036408

4,249 views
22 citations

Review

Published on 09 Jan 2023

P53 protein and the diseases in central nervous system

in Cancer Genetics and Oncogenomics

Li Lei
Qixiong Lu
Guifang Ma
Tao Li
Jiahong Deng
Weijia Li

Frontiers in Genetics

doi 10.3389/fgene.2022.1051395

6,421 views
12 citations

Review

Published on 09 Jan 2023

The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment

in Cancer Genetics and Oncogenomics

Xijia Zhou
Chang Tian
Yingshu Cao
Min Zhao
Ke Wang

Frontiers in Genetics

doi 10.3389/fgene.2022.1084609

8,147 views
26 citations

Original Research

Published on 09 Jan 2023

A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy

in Cancer Genetics and Oncogenomics

Hui Zhou
Yongxiang Wang
Zijian Zhang
Li Xiong
Zhongtao Liu
Yu Wen

Frontiers in Genetics

doi 10.3389/fgene.2022.975404

3,161 views
6 citations

Original Research

Published on 09 Jan 2023

Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Hui Jia
Wen-Jin Tang
Lei Sun
Chong Wan
Yun Zhou
Wei-Zhong Shen

Frontiers in Genetics

doi 10.3389/fgene.2022.1017866

5,094 views
9 citations

Original Research

Published on 06 Jan 2023

Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways

in Cancer Genetics and Oncogenomics

Xiong Jin
Jianlei Kang
Qing Lu
Shuang-Lei Guo
Meichen Liu
Yue Zhang
Can Cui
Hong-Lin Liu
Xin Xu
Jinlong Yin

Frontiers in Genetics

doi 10.3389/fgene.2022.1046008

4,440 views
3 citations

Original Research

Published on 06 Jan 2023

Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer

in Cancer Genetics and Oncogenomics

Kankan Zhao
Yuan Zheng
Wenliang Lu
Bo Chen

Frontiers in Genetics

doi 10.3389/fgene.2022.932027

3,385 views
3 citations

Original Research

Published on 06 Jan 2023

SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients

in Cancer Genetics and Oncogenomics

Fangshu Liu
Suqi Deng
Yue Li
Juan Du
Hui Zeng

Frontiers in Genetics

doi 10.3389/fgene.2022.1081262

5,188 views
5 citations

Original Research

Published on 06 Jan 2023

High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration

in Cancer Genetics and Oncogenomics

Yetao Zhang
Qianying Ji
Jun Wang
Yuxiang Dong
Mingyang Pang
Shengqiang Fu
Yong Wei
Qingyi Zhu

Frontiers in Genetics

doi 10.3389/fgene.2022.1100787

2,720 views
3 citations

Original Research

Published on 06 Jan 2023

Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer

in Cancer Genetics and Oncogenomics

Xuewei Xing
Yanan Tian
Xuan Jin

Frontiers in Genetics

doi 10.3389/fgene.2022.1061107

6,247 views
6 citations

Original Research

Published on 06 Jan 2023

Effect of CX3CL1/CX3CR1 gene polymorphisms on the clinical efficacy of carboplatin therapy in Han patients with ovarian cancer

in Cancer Genetics and Oncogenomics

Xin-Chen Wang
Hong Zhou
Wen-Jing Jiang
Peng Jiang
Yan-Cai Sun
Wei-Jian Ni

Frontiers in Genetics

doi 10.3389/fgene.2022.1065213

3,235 views
2 citations

Original Research

Published on 06 Jan 2023

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker

in Cancer Genetics and Oncogenomics

Wenqing Zhang
Chenglong Wu
Kaili Zhou
Yu Cao
Wange Zhou
Xue Zhang
Dan Deng

Frontiers in Genetics

doi 10.3389/fgene.2022.993438

5,133 views
3 citations

1,177 articles

articles

Cell death-related biomarker SLC2A1 has a significant role in prognosis prediction and immunotherapy efficacy evaluation in pan-cancer

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit

Editorial: Molecular basis of epigenetic regulation in cancer therapies

Epigenetic modifications in esophageal cancer: An evolving biomarker

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer

Identification and validation of a TTN-associated immune prognostic model for skin cutaneous melanoma

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma

Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer

Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia

Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of malignant progression in prostate cancer with perineural invasion

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers

Cuproptosis-associated CDKN2A is targeted by plicamycin to regulate the microenvironment in patients with head and neck squamous cell carcinoma

P53 protein and the diseases in central nervous system

The role of serine metabolism in lung cancer: From oncogenesis to tumor treatment

A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy

Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma

Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways

Identification of ubiquitination-related gene classification and a novel ubiquitination-related gene signature for patients with triple-negative breast cancer

SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients

High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration

Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer

Effect of CX3CL1/CX3CR1 gene polymorphisms on the clinical efficacy of carboplatin therapy in Han patients with ovarian cancer

Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker